Ferulic acid (4-hydroxy-3-methoxycinnamic acid) is a phenolic compound contained in rice bran and other plants. The effect of ferulic acid on blood pressure (BP) was investigated in spontaneously hypertensive rats (SHR). After oral administration of ferulic acid (1 to 100 mg/kg) to SHR, systolic blood pressure (SBP) significantly decreased in a dose-dependent manner. When oral ferulic acid (50 mg/kg) was administered to SHR, BP was lowest at 1 h and returned to basal levels at 6 h. There was a significant correlation between SHR plasma ferulic acid and changes in the SBP of the tail artery, suggesting that absorbed ferulic acid reduces BP. When 7-week-old SHR were given 10 and 50 mg/kg/d of ferulic acid for 6 weeks, increases in BP were significantly attenuated compared to SHR on the control diet. Intravenous injection of ferulic acid dose dependently reduced carotid arterial pressure in anesthetized SHR. Furthermore, the depressor effect of intravenous ferulic acid (1 mg/kg) was significantly attenuated by pretreatment of SHR with the nitric oxide (NO) synthase inhibitor N G -nitro-L-arginine methyl ester (L-NAME; 3 mg/kg, administered intravenously). These data suggest that the hypotensive effect of ferulic acid in SHR is associated with NO-mediated vasodilation. Am J Hypertens 2002;15:351-357
S
ome food components, for example, peptides from fish or milk proteins, [1] [2] [3] [4] polyunsaturated fatty acids, 5, 6 and other substances, 7-9 attenuate hypertension. Brown rice, a staple food in Japan, is also thought to be beneficial for preventing the elevation of blood pressure (BP). Rice bran contains vitamin E, dietary fiber, ␥-aminobutyric acid, inositol hexakisphosphate, and 4-hydroxy-3-methoxycinnamic acid (ferulic acid; FA). Among these components, the effects of vitamin E and ␥-aminobutyric acid on BP have been studied, 7, 10 but there have been very few studies on other food components. In the present study, we have found a depressor effect in FA, and investigated the hypotensive mechanism in spontaneously hypertensive rats (SHR).
Rice bran contains approximately 0.1% FA, a precursor of lignin, which forms the cell walls of rice and other plants. Various studies indicate that FA has a protective effect against ␤-amyloid peptide toxicity, 11 a photoprotective effect, 12 an antioxidative effect, 13 and antitumor activity. 14 -16 There are no previous reports, however, on the effects of FA in hypertensive animals or humans.
Methods

Animals
Male SHR (SHR/NCrj) and Wistar Kyoto (WKY) rats (WKY/NCrj), purchased from Charles River Japan, Inc. (Tokyo, Japan) were used. All rats were maintained at 25°Ϯ 1°C, 55% Ϯ 10% humidity, and 12-h on/off light cycle (lights on 7:00 AM to 7:00 PM). Rats had free access to a standard diet for the maintenance of rats (MF; Oriental Bio-Service Kanto Inc., Tsukuba, Japan) and to drinking water. All animal experiments were conducted at the Experimental Animal Facility of Kao Tochigi Institute. The Animal Care and Use Committee of the Kao Tochigi Institute approved the present study. All experiments strictly followed the guidelines of that committee, which adhere completely to governmental legislation in Japan.
Materials
The FA, phentolamine, nicardipine, captopril, and N Gnitro-L-arginine methyl ester (L-NAME) were purchased from Sigma Chemical Co. (St. Louis, MO). Propranolol and indomethacin were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan).
BP Measurement
Blood pressure and heart rate were measured using the tail-cuff method in conscious SHR and WKY rats. 17 After warming in a warmer at 37°C for 15 min, the rat was placed in a holder, and the BP and heart rate at the tail artery were measured using an automatic BP monitoring system (BP-98A, Softron Co., Ltd., Tokyo, Japan).
Carotid arterial pressure was measured according to the previous method. 18 Briefly, SHR were anesthetized by intraperitoneal injection of ␣-chloralose (1.5%) and urethane (7%), and a cannula was inserted into the carotid artery, and BP was recorded using a Polygraph System (Nihon Koden, Co., Tokyo, Japan).
Effects of a Single Oral Administration of FA in SHR and WKY
Dose Dependency
Because a preliminary oral treatment with FA (50 mg/kg) decreased BP in SHR (14-week-old), the doses of FA were 1, 5, 10, 25, 50, and 100 mg/kg. The FA dissolved in physiologic saline was orally administered to SHR (n ϭ 6, 14-week-old) using a stomach probe. Physiologic saline was administered to the control group. Systolic BP (SBP) and heart rate were measured 1 h after oral administration in conscious SHR according to a previous report.
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Diachronic Changes The FA (50 mg/kg) was dissolved in physiologic saline and orally administered to SHR or WKY rats (n ϭ 6, 14-week-old). Physiologic saline was administered to the control group. The SBP and heart rate were measured 0.5, 1, 2, 4, and 6 h after oral ingestion in SHR and WKY rats using the tail-cuff method.
Plasma FA Concentrations in SHR After Oral Administration of FA
The FA was administered at 50 mg/kg to SHR (male, 14-week-old). From the common jugular vein, 0.3 mL of blood was collected 0.5, 1, 2, 4, and 6 h after oral administration. At each time point, tail arterial pressure was measured, and the relation between SBP changes and log plasma FA concentration was investigated using the method by Zhou et al. 20 We modified the method reported by Tsai and Chen 21 to extract FA from the plasma and for quantification. After adding 0.5 mL of 0.5 mol/L perchloric acid solution (containing 0.1 mmol/L EDTA-2Na and 100 ng/mL dihydroxybenzylamine hydrobromide as the internal standard) to 0.1 mL of plasma, the mixture was centrifuged (20,000 g, 15 min) and the supernatant was adjusted to pH 3 with 1 mol/L sodium acetate. The supernatant was filtered using a 0.45-m filter, and 20 L was applied to a high performance liquid chromatograph with an electrochemical detector (ECD-HPLC: Eicom Co., Kyoto, Japan). The analytical conditions of HPLC were as follows: column: EICOMPAK CA-50DS 4.6 mm diameter by 150 mm length; mobile phase: 0.1 mol/L phosphate buffer (5% methanol, sodium 1-octanesulfonate 400 mg/L, EDTA-2Na 50 mg/mL); flow rate: 1 mL/min; column temperature: 25°C; detector: Eicom ECD-100 (action electrode WE-3G); voltage: ϩ550 mV v Ag/AgCl.
Long-Term Effects of FA in SHR
An MF diet was used as the control diet. The components of the MF diet were protein (23.8%), fats (5.1%), ash (6.1%), fiber (3.2%), soluble non-nitrogenous organisms (54.0%), and water (7.8%). The MF diet was combined with FA (10 or 50 mg/kg/d) as the test diet. The SHR (n ϭ 8 per group, 7-week-old at initiation of the experiment) were given the three types of diet for 6 weeks. Daily food intake, body weight, SBP, and heart rate were measured at the beginning of the experiment and at 2, 4, and 6 weeks.
Changes in Carotid Arterial BP After Intravenous Injection of FA in SHR
The SHR and WKY rats (15-week-old) were anesthetized by intraperitoneal injection of ␣-chloralose and urethane, and cannulas were inserted into the jugular vein and carotid artery. Each rat was given an intravenous injection of FA (0.5, 1 mg/kg) through the jugular catheter. Blood pressure was monitored by the carotid artery catheter on a Polygraph System (Nihon Koden, Co., Tokyo, Japan).
In SHR, infusion of FA (1 mg/kg) was followed by an intravenous injection of the ␣-adrenergic receptor antagonist phentolamine (0.1 mg/kg), 18 the ␤-adrenergic receptor antagonist propranolol (1 mg/kg), 22 the calcium channel blocker nicardipine (10 g/kg), 23 the cyclooxygenase inhibitor indomethacin (2 mg/kg), 24 or the nitric oxide synthase inhibitor L-NAME (3 mg/kg), 25 and the depressor effects of FA were observed.
Statistical Analysis
All values were expressed as means Ϯ standard error. Statistical analysis of the data was performed using StatView (SAS Institute, Tokyo, Japan). Data were initially analyzed using analysis of variance for each group. When a significant F value (P Ͻ .05) was obtained, a Duncan's multiple test was performed for post hoc analysis. A simple linear regression analysis was conducted by using Excel97 (Microsoft Co., Seattle, WA).
Results
Effects of a Single Oral Administration of FA in SHR and WKY
Dose Dependency
The initial SBP values of 14-weekold SHR were 207 Ϯ 2 mm Hg. The change in SBP was Ϫ0.3% Ϯ 1.1% at 1 h after oral administration of saline. After oral administration of FA, the changes in SBP were Ϫ0.9% Ϯ 0.9% (1 mg/kg), Ϫ4.0% Ϯ 0.5% (5 mg/kg; P Ͻ .05 v saline group), Ϫ7.1% Ϯ 1.1% (10 mg/kg; P Ͻ .05), Ϫ9.2% Ϯ 0.9% (25 mg/kg; P Ͻ .01), Ϫ11.0% Ϯ 1.1% (50 mg/kg, P Ͻ .01), or Ϫ10.8% Ϯ 1.0% (100 mg/kg, P Ͻ .01) (Fig. 1) . The depressor effect was nearly constant with 50 mg/kg. At 1 h after oral administration of captopril (10 mg/kg), an angiotensin converting enzyme inhibitor, the reduction of BP was Ϫ10.3% Ϯ 0.4% (P Ͻ .001) (data not shown).
Diachronic Changes
The changes in BP after a single oral administration of FA (50 mg/kg) to SHR or WKY rats (14-week-old) are shown in Table 1 . The SBP value in SHR after administration of saline was almost constant for 6 h. When FA was administered to SHR, there was significant hypotension at 0.5 h, with the lowest point at 1 h. A significant depressor effect of FA was observed until 4 h, but there was no significant difference at 6 h. The FA administration did not change the BP in normotensive WKY rats. Changes in heart rate in SHR or WKY rats were not observed until 6 h after administration.
Relationship Between SBP Changes and Plasma FA Concentrations
Regression analysis was performed on the relation between plasma FA concentrations and the rates of SBP reduction in SHR after the administration of FA. A significant negative correlation (r ϭ 0.5005, P Ͻ .01) was observed between log plasma FA concentrations and SBP changes (Fig. 2) .
Long-Term Effects of FA in SHR
The results are shown in Table 2 . During the 6-week study period, there were no significant differences in daily food
FIG. 1.
Effects of a single oral administration of ferulic acid (FA) on systolic blood pressure (SBP) in conscious spontaneously hypertensive rats (SHR). SBP was measured 1 h after oral ingestion of FA using by the tail-cuff method in conscious SHR. Each value represents the mean Ϯ SE of six rats. *P Ͻ .05, **P Ͻ .01, significantly different from the saline group. FA ϭ ferulic acid; HR ϭ heart rate; SBP ϭ systolic blood pressure; SHR ϭ spontaneously hypertensive rats; WKY ϭ Wister Kyoto rats. Each value represents the mean Ϯ SE (n ϭ 6). Change in SBP (mm Hg) is indicated by the value of (SBP after administration) Ϫ (SBP before administration). * P Ͻ .01 and † P Ͻ .001 control v FA.
intake and body weight between the FA diet and control diet groups in SHR. Tail SBP before ingestion in the control diet group and the 10-and 50-mg/kg FA diet groups were 163, 166, and 168 mm Hg, respectively. In the control diet group, BP gradually increased with age and reached 202 mm Hg in week 6 (13-week-old) after initiation. In the FA diet groups, the increase in BP was significantly attenuated compared to the control diet group in a dose-dependent manner. There were no significant differences in heart rate between the control diet and FA diet groups in SHR.
Changes in Carotid Arterial Pressure After Intravenous Injection of FA in Anesthetized SHR or WKY Rats
The FA was intravenously injected and changes in carotid arterial pressure were observed in anesthetized SHR or WKY rats (Fig. 3) . When 0.5 and 1 mg/kg of FA were administered, SBP decreased slightly after injection in WKY rats. There was a significant reduction of SBP when FA was administered to SHR.
Pretreatment with phentolamine, propranolol, nicardi-
FIG. 2.
Relationship between SBP changes and plasma ferulic acid concentrations. Abbreviation as in Fig. 1 . Table 2 . Body weight, food intake, heart rate, and systolic blood pressure during the 6-week experimental period in SHR pine, or indomethacin did not affect the depressor effect of FA (Table 3) . When L-NAME was intravenously injected to SHR before the infusion of FA, the hypotensive effect of FA was significantly attenuated.
Group
Discussion
The present study investigated the effects of FA on BP in SHR and WKY rats. The FA had a hypotensive effect and attenuated the elevation of BP in SHR. The significant inhibition of the depressor effect of FA by the intravenous injection of L-NAME suggests that the hypotensive effect of FA was associated with nitric oxide (NO)-mediated vasodilation. The FA had little influence on BP in WKY rats. This finding is consistent with previous reports 26, 27 that FA had no effect on BP in normotensive animals. Orally administered FA is metabolized to phenolic iv ϭ intravenous injection; L-NAME ϭ N G -nitro-L-arginine methyl ester; other abbreviations as in Table 1 and 2. * change in SBP (%) is indicated by the value of [(SBP after FA infusion)Ϫ(SBP after vehicle infusion)]/(SBP after vehicle infusion) ϫ 100; † SBP of vehicle or FA (1 mg/kg, iv) infusion before antagonists and blockers; ‡ SBP of vehicle or FA infusion after administration of antagonists and blockers; § P Ͻ .001 control v before L-NAME treatment.
compounds (eg, vanillic acid or dihydroferulic acid) in rat circulation. 28 We investigated the relationship between plasma FA concentrations and the rates of SBP reduction in SHR after administration of FA. There was a significant negative correlation. The data suggested that circulating FA reduces BP in SHR.
Changes in carotid arterial pressure by FA infusion were tested after intravenous injection of various antagonists and blockers. The L-NAME significantly inhibited the depressor effect of FA; however, phentolamine, propranolol, nicardipine, or indomethacin did not. These data suggest that the hypotensive effect of FA in SHR is associated with NO-mediated vasodilation. Many investigators recently reported that SHR arteries have increased superoxide anion production compared to WKY rats, and that this reacts with NO, thereby effectively depleting NO in vascular endothelial cells. 29, 30 Also, BP in SHR is markedly reduced by treatment with superoxide dismutase, which has a high affinity for heparin sulfate, or by inhibition of xanthine oxidase. 31, 32 Because FA is reported to scavenge superoxide anions, 33 it might be that FA improves the bioavailability of NO in blood vessels in SHR. The possibility that FA acts specifically on blood vessels in SHR to cause a relaxation response is supported by the fact that FA had no influence on BP in WKY rats (Fig. 3,  Table 1 ) or on heart rate in SHR and WKY rats (Tables 1  and 2 ).
The results of this study suggest that FA can improve hypertension with no influence on normotension or on cardiac function. Therefore, the use of FA might be beneficial to prevent hypertension.
